At the time of writing, Revolution Medicines Inc [RVMD] stock is trading at $31.13, down -0.86%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The RVMD shares have lost -7.41% over the last week, with a monthly amount drifted -15.45%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Revolution Medicines Inc [NASDAQ: RVMD] stock has seen the most recent analyst activity on July 16, 2024, when Needham reiterated its Buy rating and also boosted its price target to $62 from $46. Previously, Barclays started tracking the stock with Overweight rating on July 12, 2024, and set its price target to $52. On July 08, 2024, Jefferies initiated with a Buy rating and assigned a price target of $63 on the stock. Needham reiterated its Buy rating and increased its price target to $46 on April 12, 2024. Raymond James upgraded its rating to a Strong Buy and raised its price target to $48 on April 10, 2024. Piper Sandler started tracking with a Overweight rating for this stock on March 11, 2024, and assigned it a price target of $43. In a note dated January 05, 2024, BofA Securities upgraded an Buy rating on this stock and boosted its target price from $31 to $34.
For the past year, the stock price of Revolution Medicines Inc fluctuated between $29.17 and $62.40. Currently, Wall Street analysts expect the stock to reach $68.17 within the next 12 months. Revolution Medicines Inc [NASDAQ: RVMD] shares were valued at $31.13 at the most recent close of the market. An investor can expect a potential return of 118.98% based on the average RVMD price forecast.
Analyzing the RVMD fundamentals
According to Revolution Medicines Inc [NASDAQ:RVMD], the company’s sales were 0.00M for trailing twelve months, which represents an -100.00% plunge. To continue investigating profitability, this company’s Return on Assets is posted at -0.23, Equity is -0.33 and Total Capital is -0.29. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.06.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 30.13 points at the first support level, and at 29.13 for the second support level. However, for the 1st resistance point, the stock is sitting at 32.67, and for the 2nd resistance point, it is at 34.21.
Ratios To Look Out For
It is important to note that Revolution Medicines Inc [NASDAQ:RVMD] has a current ratio of 14.20. Also, the Quick Ratio is 14.20, while the Cash Ratio stands at 3.31.
Transactions by insiders
Recent insider trading involved Cislini Jeff, General Counsel, that happened on Mar 20 ’25 when 2041.0 shares were sold. Officer, JEFFREY TODD CISLINI completed a deal on Mar 20 ’25 to buy 2041.0 shares. Meanwhile, General Counsel Cislini Jeff sold 1458.0 shares on Mar 17 ’25.
